Yuji Mano
Drug Metabolism Research Laboratories
Astellas Pharma Inc.
1-8, Azusawa 1-chome
Itabashi-ku
Japan
Name/email consistency: medium
- Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver. Mano, Y., Usui, T., Kamimura, H. Eur. J. Clin. Pharmacol. (2007)
- Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver. Mano, Y., Usui, T., Kamimura, H. Drug Metab. Dispos. (2007)
- Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2. Mano, Y., Usui, T., Kamimura, H. Biopharm. Drug. Dispos (2007)
- Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes. Mano, Y., Usui, T., Kamimura, H. Eur. J. Clin. Pharmacol. (2007)
- Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes. Mano, Y., Usui, T., Kamimura, H. Drug Metab. Dispos. (2007)
- In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid. Mano, Y., Usui, T., Kamimura, H. Biopharm. Drug. Dispos (2006)
- In vitro drug interaction between diflunisal and indomethacin via glucuronidation in humans. Mano, Y., Usui, T., Kamimura, H. Biopharm. Drug. Dispos (2006)
- Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver. Mano, Y., Usui, T., Kamimura, H. Pharm. Res. (2006)